Adult respiratory distress syndrome complicating intravenous infusion of low-molecular weight dextran.

Autor: Taylor MA; Department of Cardiology, Deborah Heart and Lung Center, Browns Mills, NJ 08015., DiBlasi SL, Bender RM, Santoian EC, Cha SD, Dennis CA
Jazyk: angličtina
Zdroj: Catheterization and cardiovascular diagnosis [Cathet Cardiovasc Diagn] 1994 Jul; Vol. 32 (3), pp. 249-53.
DOI: 10.1002/ccd.1810320310
Abstrakt: Respiratory failure is one of the most uncommon and serious adverse drug reactions. Low-molecular-weight-dextran (Dextran-40) is a useful adjunctive anti-platelet agent in the setting of coronary angioplasty and intracoronary stent placement. We report the occurrence of the adult respiratory distress syndrome following intravenous infusion of Dextran-40.
Databáze: MEDLINE